EBS Competitors & Alternatives

Compare Emergent Biosolutions Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

EBS

Main Stock
$7.41
Tradestie Score
44
Market Cap
$490.30M
Revenue Growth
-0.3%
Analyst Upside
+61.9%

Top Competitors

46 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
XERS Xeris Biopharma Holdings, Inc. Common Stock
$8.13
$1.29B 115.4 60 Compare
AMPH Amphastar Pharmaceuticals, Inc.
$20.22
$1.25B 12.0 51 Compare
DVAX Dynavax Technologies Corporation
$15.50
$1.21B - 55 Compare
PCRX Pacira BioSciences, Inc. Common Stock
$26.92
$1.14B 203.2 55 Compare
COLL Collegium Pharmaceutical, Inc. Common Stock
$35.58
$1.11B 17.2 52 Compare
CRON Cronos Group Inc. Common Share
$2.83
$1.02B - 60 Compare
VIR Vir Biotechnology, Inc. Common Stock
$8.90
$791.82M - 49 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 55 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$45.14
$543.32M - 56 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.42
$237.15M 5.7 57 Compare

Data updated: Aug 03, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

46 stocks in this industry